Applicant, as named in the Orange Book

King Pharms

Pfizer Inc · NYSE: PFE

Company and ticker: cliffwatch mapping, checked against SEC EDGAR · SEC filings

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis

None.

Levoxyl · Generic approved · ANDA 216370, AlembicApproved 20 May 2026Detected 25 Oct 2026

Products without listed protection (2)

Drug	Ingredient	Earliest generic entry	Basis
Cytomel NDA 010379 · 3 strengths liothyronine sodium	liothyronine sodium	open now no listed protection	no listed protection
Levoxyl NDA 021301 · 11 strengths levothyroxine sodium	levothyroxine sodium	open now no listed protection	no listed protection